SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000059478-21-000171
Filing Date
2021-08-03
Accepted
2021-08-03 12:04:04
Documents
69
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q lly-20210630.htm   iXBRL 10-Q 2891787
2 EX-31.1 lly-6302021x10qxexhibit311.htm EX-31.1 10803
3 EX-31.2 lly-6302021x10qxexhibit312.htm EX-31.2 10778
4 EX-32 lly-6302021x10qxexhibit32.htm EX-32 7208
  Complete submission text file 0000059478-21-000171.txt   12230118

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT lly-20210630.xsd EX-101.SCH 54836
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT lly-20210630_cal.xml EX-101.CAL 73866
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT lly-20210630_def.xml EX-101.DEF 274743
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT lly-20210630_lab.xml EX-101.LAB 646840
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT lly-20210630_pre.xml EX-101.PRE 413058
10 EXTRACTED XBRL INSTANCE DOCUMENT lly-20210630_htm.xml XML 3199574
Mailing Address LILLY CORPORATE CENTER DROP CODE 1094 INDIANAPOLIS IN 46285
Business Address LILLY CORPORATE CTR DROP CODE 1094 INDIANAPOLIS IN 46285 3172762000
ELI LILLY & Co (Filer) CIK: 0000059478 (see all company filings)

IRS No.: 350470950 | State of Incorp.: IN | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-06351 | Film No.: 211138622
SIC: 2834 Pharmaceutical Preparations